-
Novartis Oral PNH New Drug Approved by FDA for Market, Effectively Increasing Hemoglobin Levels
Novartis Pharmaceuticals announced on December 6th that the US Food and Drug Administration (FDA) has approved the launch of its Fabhalta (iptacopan), which is the first FDA approved oral monotherapy ... -
Pfizer Announces Approval of Oral Migraine New Drug "Rimezepam orally disintegrating tablets" in China
According to AI News, on January 26th, Pfizer Pharmaceuticals announced on its official WeChat account that the new generation of specific migraine treatment drug, Rimezepam orally disintegrating tab ... -
Pfizer Announces Approval of Oral Migraine New Drug "Rimezepam orally disintegrating tablets" in China
On January 26th, Pfizer announced that its new generation of specific migraine treatment drug, Rimezepam orally disintegrating tablets, has been approved by the National Medical Products Administrati ... -
New weight loss medicine surpasses Tesla! How does investor preference transfer affect the US stock market?
Suddenly, new weight loss drugs have replaced electric vehicles and become the "hot potato" in the eyes of US stock investors in early 2024. As a result, Eli Lilly&Co., the market leader in new weigh ... -
Surprisingly! FDA Delays Approval of Eli Lilly's New Drug for Alzheimer's Disease
Surprisingly! US FDA Delays Approval of Eli Lilly's New Drug for Alzheimer's Disease: US pharmaceutical giant Eli Lilly announced on Friday that the US Food and Drug Administration (FDA) has unexpect ... -
The Novo Nordisk Foundation collaborates with Nvidia to develop an AI supercomputer for the discovery of new drugs and therapies
Huang Renxun has repeatedly referred to "AI+healthcare systems/biology" as the "next amazing revolution" in various public occasions, and his concept has also received genuine support from the pharma ... -
How is the progress of the world's first new drug for schizophrenia approved in the US and in the Chinese market
On September 26th local time, the US Food and Drug Administration (FDA) announced the approval of BMS's schizophrenia drug Cobenfy (KarXT, xanomiline and trospium chloride) for the treatment of adult ...